城建發展(600266.SH):擬與集團公司續簽《股權託管協議》
格隆匯6月5日丨城建發展(600266.SH)公佈,爲解決與集團公司全資子公司開發公司的同業競爭問題,公司與集團公司於2022年6月簽署了《股權託管協議》,該協議將於2025年6月30日到期。爲避免同業競爭,滿足監管要求,公司擬與集團公司續簽《股權託管協議》,集團公司將開發公司100%股權託管給公司,公司按開發公司年度審計報告確認的年度營業收入的0.2%計算託管費用。
本次交易的交易對方集團公司爲公司的控股股東,根據《上海證券交易所股票上市規則》規定,集團公司爲公司的關聯法人,因此本次交易構成關聯交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.